DVL1 and pituitary tumor: To assess whether Wnt pathway inhibitors are able to modulate Sstr2-dependent suppression of GH secretion, GH3 rat pituitary tumor cells were treated for 4 h with the pan-Dvl PDZ domain inhibitor and then stimulated for 15 min with octreotide.